Alternative route into Asia? Think small
This article was originally published in Clinica
Singapore may be small but over the last decade, measures to strengthen its medtech ecosystem have enabled the country to serve as a useful springboard for companies wanting to launch themselves into the wider Asian market. In an interview with Associate Professor Sze Wee Tan, deputy executive director of Biomedical Research Council and the man in charge of developing Singapore’s medtech cluster, Tina Tan finds out how the country has built a thriving medtech ecosystem that is now attracting international attention. She also chats to some local medtech entrepreneurs to find out about their experiences of innovating in Singapore
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.